Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Change in Inventory (2020 - 2025)

Maravai Lifesciences Holdings has reported Change in Inventory over the past 6 years, most recently at -$3.1 million for Q4 2025.

  • Quarterly results put Change in Inventory at -$3.1 million for Q4 2025, down 584.07% from a year ago — trailing twelve months through Dec 2025 was -$8.0 million (down 2021.75% YoY), and the annual figure for FY2025 was -$8.0 million, down 2021.75%.
  • Change in Inventory for Q4 2025 was -$3.1 million at Maravai Lifesciences Holdings, down from -$1.3 million in the prior quarter.
  • Over the last five years, Change in Inventory for MRVI hit a ceiling of $13.8 million in Q1 2021 and a floor of -$19.3 million in Q4 2022.
  • Median Change in Inventory over the past 5 years was -$450500.0 (2024), compared with a mean of $154500.0.
  • Biggest five-year swings in Change in Inventory: surged 381.68% in 2023 and later tumbled 584.07% in 2025.
  • Maravai Lifesciences Holdings' Change in Inventory stood at -$5.5 million in 2021, then tumbled by 251.89% to -$19.3 million in 2022, then skyrocketed by 111.33% to $2.2 million in 2023, then crashed by 120.7% to -$452000.0 in 2024, then tumbled by 584.07% to -$3.1 million in 2025.
  • The last three reported values for Change in Inventory were -$3.1 million (Q4 2025), -$1.3 million (Q3 2025), and -$3.1 million (Q2 2025) per Business Quant data.